Royal Capital Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Royal Capital Wealth Management's LLY Position: Q2 2026 in Review
Royal Capital Wealth Management increased its Eli Lilly (LLY) stake by 6% in Q2 2026, buying an estimated $237K and bringing the position to 4,097 shares worth $4.91M. The position accounts for 2.76% of the portfolio, ranked #12.
Royal Capital Wealth Management first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Royal Capital Wealth Management held 4,097 shares of Eli Lilly worth $4.91M as of Q2 2026.
- Royal Capital Wealth Management bought 232 Eli Lilly shares in Q2 2026, an estimated $237K.
- Eli Lilly made up 2.76% of Royal Capital Wealth Management's portfolio in Q2 2026, its #12 holding.
- Royal Capital Wealth Management first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Royal Capital Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.